{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:12Z","timestamp":1772119452952,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001343","name":"University of Pretoria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001343","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Antimicrobial resistance (AMR) is important in the pathogenesis and spread of\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection (CDI). However, very little is known about the association of AMR and\n                      <jats:italic>C. difficile<\/jats:italic>\n                      in South Africa. The present study aimed to investigate the phenotypic and genotypic antimicrobial profiles of clinical\n                      <jats:italic>C. difficile<\/jats:italic>\n                      isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Phenotypic antimicrobial susceptibility testing (AST) and whole genome sequencing (WGS) were used to characterize the isolates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The AST showed that 43 isolates were susceptible to metronidazole and vancomycin. The WGS revealed a\n                      <jats:italic>PnimB<\/jats:italic>\n                      promoter mutation associated with reduced metronidazole susceptibility in all sequence type (ST) 1 strains (42%, 18\/43). No vancomycin resistance determinants were found. Distinct lineages displayed specific resistance traits, such as fluoroquinolone resistance in ST1 strains due to a DNA gyrase (\n                      <jats:italic>gyrA<\/jats:italic>\n                      ) mutation (\n                      <jats:italic>Thr82Ile<\/jats:italic>\n                      ) and multidrug resistance (MDR) in ST37 strains, which contained resistance determinants for five antimicrobial classes. Overall, 95% (40\/43) of strains had AMR determinants for at least three antimicrobial classes, indicating MDR. A\n                      <jats:italic>qacG<\/jats:italic>\n                      efflux pump gene, conferring resistance to disinfectants, was found in all strains.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Antimicrobial resistance to metronidazole and vancomycin remains rare, however, high MDR prevalence particularly among ST1 and ST37 strains, suggests a risk of AMR gene transmission to other pathogens. The high rate of MDR\n                      <jats:italic>C. difficile<\/jats:italic>\n                      may reflect extensive antimicrobial use driven by comorbidities in immunocompromised individuals, contributing to AMR. These findings underscore the importance of ongoing AMR surveillance, effective antimicrobial stewardship and infection control to manage CDI and mitigate AMR spread.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-025-05205-6","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T11:13:30Z","timestamp":1752146010000},"page":"2439-2445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic and genotypic antimicrobial resistance profiles of clinical Clostridioides difficile isolates collected from private and public health settings in South Africa"],"prefix":"10.1007","volume":"44","author":[{"given":"Hlambani","family":"Shirinda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Prinsloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishalan","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marleen M.","family":"Kock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marthie M.","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"5205_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/dkac342","volume":"78","author":"OJ Okolie","year":"2023","unstructured":"Okolie OJ, Igwe U, Ismail SU, Ighodalo UL, Adukwu EC (2023) Systematic review of surveillance systems for AMR in Africa. J Antimicrob Chemother 78:31\u201351. https:\/\/doi.org\/10.1093\/jac\/dkac342","journal-title":"J Antimicrob Chemother"},{"key":"5205_CR2","doi-asserted-by":"publisher","unstructured":"Tang KWK, Millar BC, Moore JE (2023) Antimicrobial resistance (AMR). Br J Biomed Sci 80. https:\/\/doi.org\/10.3389\/bjbs.2023.11387","DOI":"10.3389\/bjbs.2023.11387"},{"key":"5205_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ijmmb.2022.07.018","volume":"40","author":"DS Blanc","year":"2022","unstructured":"Blanc DS, Poncet F, Grandbastien B, Prod\u2019hom G, Greub G, Senn L (2022) Molecular typing of Clostridioides difficile from frozen stool samples to investigate cross-transmissions: a proof of concept. Indian J Med Microbiol 40:531\u2013535. https:\/\/doi.org\/10.1016\/j.ijmmb.2022.07.018","journal-title":"Indian J Med Microbiol"},{"key":"5205_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/EBC20160062","volume":"61","author":"P Harnvoravongchai","year":"2017","unstructured":"Harnvoravongchai P, Pipatthana M, Chankhamhaengdecha S, Janvilisri T (2017) Insights into drug resistance mechanisms in Clostridium difficile. Essays Biochem 61:81\u201388. https:\/\/doi.org\/10.1042\/EBC20160062","journal-title":"Essays Biochem"},{"key":"5205_CR5","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000696","author":"K Imwattana","year":"2021","unstructured":"Imwattana K, Rodr\u00edguez C, Riley TV, Knight DR (2021) A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile. Microb Genom 7. https:\/\/doi.org\/10.1099\/mgen.0.000696","journal-title":"Microb Genom"},{"key":"5205_CR6","doi-asserted-by":"publisher","unstructured":"Nana T, Moore C, Boyles T, Brink AJ, Cleghorn J, Devenish LM, Lowman W (2020) South African society of clinical microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline. S Afr J Infect Dis 35. https:\/\/doi.org\/10.4102\/sajid.v35i1.219","DOI":"10.4102\/sajid.v35i1.219"},{"key":"5205_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jiac.2021.12.011","volume":"28","author":"H Kunishima","year":"2022","unstructured":"Kunishima H, Ohge H, Suzuki H, Nakamura A, Matsumoto K, Mikamo H, Mori N, Morinaga Y, Yanagihara K, Yamagishi Y, Yoshizawa S (2022) Japanese clinical practice guidelines for management of Clostridioides (Clostridium) difficile infection. J Infect Chemother 28:1045\u20131083. https:\/\/doi.org\/10.1016\/j.jiac.2021.12.011","journal-title":"J Infect Chemother"},{"key":"5205_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.cmi.2017.12.022","volume":"24","author":"RE Ooijevaar","year":"2018","unstructured":"Ooijevaar RE, van Beurden YH, Terveer EM, Goorhuis A, Bauer MP, Keller JJ, Mulder CJJ, Kuijper EJ (2018) Update of treatment algorithms for Clostridium difficile infection. Clin Microbiol Infect 24:452\u2013462. https:\/\/doi.org\/10.1016\/j.cmi.2017.12.022","journal-title":"Clin Microbiol Infect"},{"key":"5205_CR9","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2024) Breakpoint tables for interpretation of MICs and zone diameters, version 14.0"},{"key":"5205_CR10","doi-asserted-by":"publisher","first-page":"102926","DOI":"10.1016\/j.anaerobe.2024.102926","volume":"91","author":"H Shirinda","year":"2025","unstructured":"Shirinda H, Smith AM, Prinsloo B, Kock MM, Moodley M, Said M, Ehlers MM (2025) Clostridioides difficile hypervirulent strain ST1 isolated from clinical stool specimens obtained from three provinces in South Africa. Anaerobe 91:102926. https:\/\/doi.org\/10.1016\/j.anaerobe.2024.102926","journal-title":"Anaerobe"},{"key":"5205_CR11","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1038\/s41467-023-39429-x","volume":"14","author":"AO Olaitan","year":"2023","unstructured":"Olaitan AO, Dureja C, Youngblom MA, Topf MA, Shen WJ, Gonzales-Luna AJ, Deshpande A, Hevener KE, Freeman J, Wilcox MH, Palmer KL, Garey KW, Pepperell CS, Hurdle JG (2023) Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile. Nat Commun 14:4130. https:\/\/doi.org\/10.1038\/s41467-023-39429-x","journal-title":"Nat Commun"},{"key":"5205_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/ajlm.v7i2.846","volume":"7","author":"BR Kullin","year":"2018","unstructured":"Kullin BR, Reid S, Abratt V (2018) Clostridium difficile in patients attending tuberculosis hospitals in cape town, South africa, 2014\u20132015. Afr J Lab Med 7:1\u20139. https:\/\/doi.org\/10.4102\/ajlm.v7i2.846","journal-title":"Afr J Lab Med"},{"key":"5205_CR13","doi-asserted-by":"publisher","first-page":"20607","DOI":"10.1038\/s41598-024-71492-2","volume":"14","author":"O Schwartz","year":"2024","unstructured":"Schwartz O, Rohana H, Azrad M, Shor A, Rainy N, Maor Y, Peretz A (2024) Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in israel, 2020\u20132022. Sci Rep 14:20607. https:\/\/doi.org\/10.1038\/s41598-024-71492-2","journal-title":"Sci Rep"},{"key":"5205_CR14","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s10096-021-04302-8","volume":"40","author":"K O\u2019Grady","year":"2021","unstructured":"O\u2019Grady K, Knight DR, Riley TV (2021) Antimicrobial resistance in Clostridioides difficile. Eur J Clin Microbiol Infect Dis 40:2459\u20132478. https:\/\/doi.org\/10.1007\/s10096-021-04302-8","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5205_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/microorganisms9071383","volume":"9","author":"P Kartalidis","year":"2021","unstructured":"Kartalidis P, Skoulakis A, Tsilipounidaki K, Florou Z, Petinaki E, Fthenakis GC (2021) Clostridioides difficile as a dynamic vehicle for the dissemination of antimicrobial-resistance determinants: review and in Silico analysis. Microorganisms 9:1383. https:\/\/doi.org\/10.3390\/microorganisms9071383","journal-title":"Microorganisms"},{"key":"5205_CR16","doi-asserted-by":"publisher","first-page":"106824","DOI":"10.1016\/j.ijantimicag.2023.106824","volume":"62","author":"A Plankaova","year":"2023","unstructured":"Plankaova A, Brajerova M, Capek V, Novotna GB, Kinross P, Skalova J, Krutova M (2023) Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018\u20132019. Int J Antimicrob Agents 62:106824. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106824","journal-title":"Int J Antimicrob Agents"},{"key":"5205_CR17","doi-asserted-by":"publisher","unstructured":"Kullin B, Abratt VR, Reid SJ, Riley TV (2022) Clostridioides difficile infection in africa: a narrative review. Anaerobe 74. https:\/\/doi.org\/10.1016\/j.anaerobe.2021.102547","DOI":"10.1016\/j.anaerobe.2021.102547"},{"key":"5205_CR18","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/jac\/dkab099","volume":"76","author":"P Putsathit","year":"2021","unstructured":"Putsathit P, Hong S, George N, Hemphill C, Huntington PG, Korman TM, Knight DR (2021) Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015\u201318. J Antimicrob Chemother 76:1815\u20131821. https:\/\/doi.org\/10.1093\/jac\/dkab099","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05205-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05205-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:45:46Z","timestamp":1759239946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05205-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5205"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05205-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5436251\/v1","asserted-by":"object"}]},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics clearance (number 612\/2022) was obtained from the Research Ethics Committee of the Faculty of Health Sciences, University of Pretoria. Permission letters to collect stool specimens were obtained from public and private sector diagnostic laboratories.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}